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INTRODUCTION
Patients with major affective and anxiety disorders frequent-
ly experience psychosocial impairment and multiple dysfunc-
tions.1-3 Psychoactive medications together with other treat-
ment options are commonly used to minimize, at least partially, 
these negative outcomes in major psychiatric conditions. 
Given the detrimental consequences of these disabling con-
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ditions either at individual and social levels, researchers are 
encouraged to identify factors that may help to better predict 
illness trajectories as well as early management and adequate 
treatment.
Studies highlighted the involvement of sensory perception 
in emotional processes. It has been suggested that Sensory 
Processing Disorders (SPD) may be significantly involved in 
psychopathological processes and directly contribute to im-
paired daily functioning.4,5 The term “sensory intolerance” 
has been recently used in the current literature6 and is also rec-
ognized as SPD. SPD encompass difficulties in registering and 
modulating sensory information and organizing sensory input 
to perform successful adaptive responses to situational de-
mands.7,8 Hyposensitivity may be expressed by either a pattern 
of low registration in which individuals fail to detect sensation 
and do not actively seek for sensory input, or sensation seek-
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ing in which individuals enjoy rich and intensive sensory en-
vironments and activities. Conversely, hypersensitivity, ex-
pressed in either a pattern of sensory sensitivity in which in-
dividuals feel discomfort with regular sensations but do not 
actively limit their exposure to them, or sensation avoidance 
in which people actively limit exposure to unpleasant sensa-
tions.9 
Evidence also suggested the importance to identify the main 
predictors associated with a poor outcome in patients with 
anxiety and affective disorders. Longer duration of illness ep-
isodes have been associated with higher recurrences of the 
illness and chronicity10,11 which are related, in turn, with high-
er social/functional impairments12,13 as well as poorer response 
to treatment14-16 when compared with less persistent illness ep-
isodes. Furthermore, a delay in initiating treatments has been 
suggested as one of the most relevant predictor of non-response 
to treatments and poor functional outcome.17,18 
Similarly, the severity of side effects has been reported as a 
predictor of poor treatment adherence negatively influencing 
the long-term outcome of patients with major affective disor-
ders19,20 and potentially enhancing treatment resistance as well 
as the neurobiological sequelae associated with the illness.21 
However, although their influence on the outcome of pa-
tients with anxiety and affective disorders has been widely 
demonstrated, the relationship between SPD, duration of un-
treated illness and current illness episode together with se-
verity of side effects related to psychoactive medications has 
not been systematically investigated.
Here, we aimed to investigate the association between SPD, 
duration of untreated illness and current illness episode as 
well as severity of medications side effects in a sample of psy-
chiatric outpatients. Based on previous studies examining 
the impact of SPD and sensory over-responsivity in healthy 
young individuals,9,22,23 adults22-25 and different populations of 
patients (e.g., children with disabilities or healthy individu-
als),26-29 we hypothesized that the longer duration of current ill-
ness episode and untreated illness together with the higher 
severity of medications side effects may correlate with specific 
SPD patterns.
METHODS
Sample
The sample included 178 participants with an age ranging 
from 17 to 85 years (mean=53.84±15.55). Participants were 
distributed as follows: 50% of them were diagnosed with uni-
polar Major Depressive Disorder (MDD), 33.7% with Bipolar 
Disorder (BD) type I and type II, and 16.3% with Anxiety dis-
orders (AD). All participants were consecutively admitted to 
the Department of Neuroscience (DINOGMI), University of 
Genoa, between July and December 2014. Psychiatric histo-
ries were carefully collected using all the available cross-sec-
tional and retrospective information: medical records, infor-
mation from the treatment team, and additional information 
from family or friends. All subjects were diagnosed using the 
Diagnostic and Statistical Manual of Mental Disorders crite-
ria (DSM-IV, TR)30 and the Mini International Neuropsychi-
atric Interview (MINI).31 Exclusion criteria were any condi-
tions affecting the ability to fill out the assessment, including 
delirium, dementia or any severe neurological diseases, and 
denial of the informed consent. Significant discrepancies be-
tween these sources served as further criteria for exclusion 
from the study. All the patients accepted voluntarily to par-
ticipate in the study and gave regularly their informed con-
sent. The study design was approved by the local ethical re-
view board. Table 1 summarizes the most relevant participants’ 
socio-demographic and health related information in each 
diagnostic group.
Measures
Demographic questionnaire. In this self-report question-
naire respondents answered questions about: health status, so-
cio-demographic status, psychoactive and non-psychoactive 
medications. 
The Adolescent/Adult Sensory Profile (AASP)32 is a self-
measure psychometric tool with 60 items, sorted into four 
patterns reflecting Dunn’s model.9 Participants indicate the 
frequency of their behavioural responses to sensory experi-
ences in daily life on a five-point Likert scale. In the present 
study, the five ranges for each sensory processing pattern, as 
presented in the AASP manual were merged into: 1) “Less 
than most people” [representing approximately 16% of the 
population, or more than one standard deviation (SD) below 
the mean]; 2) “Similar to most people” (representing approx-
imately 68% of the population between -1 SD and +1 SD); 3) 
“More than most people” (representing approximately 16% of 
the population, or more than 1 SD above the mean). The AASP 
is currently under validation in Italian language.
The Udvalg for Kliniske Undersøgelser (UKU) measured 
pharmacological treatment side effects and their severity.33 
The severity and the perception or assessment that a symptom 
is a side effect was assessed as follows: 0=no, 1=mild, 2=mod-
erate, 3=severe side effect. The UKU Scale is divided into four 
sections evaluating psychiatric symptoms (10 items), neuro-
logical symptoms (8 items), autonomic symptoms (11 items), 
and other effects (19 items), respectively. 
Current episode duration/duration of untreated illness. 
Current episode duration has been measured by clinicians in 
days whereas duration of untreated illness has been retrospec-
tively retraced in years based on the clinical history.
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Table 1. Participants’ socio-demographic information in each group
Socio-demographic information Unipolar (N=89), % Bipolar (N=60), % Anxiety (N=29), %
Gender
Male 32.6 35 41.4
Female 67.4 65 58.6
Level of education
Elementary schools 7.9 8.3 3.4
Junior high schools 32.6 30 41.4
Secondary schools 52.8 43.3 51.7
Academy 6.7 18.3 3.4
Marital status
Single 30.3 28.3 48.3
Married 46.1 58.3 31
Divorced 13.5 11.7 17.2
Widowed 10.1 1.7 3.4
Living with
Alone 22.5 15 31
Family 73 83.3 65.5
Friend 4.5 1.7 3.4
Missing 0 0 0
Employment
Employed 39.3 46.7 44.8
Unemployed 27 26.7 31
Retired 31.5 26.7 20.7
Student 1.1 0 3.4
Missing 1.1 0 0
Socio-economic status
Below average 39.3 45 58.6
Average 55.1 46.7 41.4
Above average 5.6 8.3 0
Significant distressing life events in the last 6 months
No 50.6 80 79.3
Yes 48.3 20 20.7
Missing 1.1 0 0
Age of illness onset
Range
Mean±SD
10–85
47.54±16.21
8–56
32.03±12.75
13–78
44.79±17.02
Illness duration in years
Range
Mean±SD
0.3–60
11.36±15.26
0.5–65
19.82±17.74
0.5–52
10.13±13.73
Subjects who use antidepressants
Mean 39.3 15.2 12.9
Subjects who use mood stabilizers
Mean 7.3 24.1 3.9
Subjects who use antipsychotic agents
1st generation
2nd generation
2.2
5
2.5
9.5
0
3.4
Subjects who use benzodiazepines 
Mean 30.3 16.8 14
SD: standard deviation
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Statistical analysis
All the analyses were performed using the Statistical Pack-
age for Social Sciences (SPSS) for Windows 19.0. The correla-
tions between all dependent variables were examined by Pear-
son correlation test. p values≤0.05 were considered statistically 
significant. 
RESULTS
Frequency of SPD as presented by the percentage 
of participants in each sensory processing 
performance range for every diagnostic group
As presented in Table 2, low registration was found under 
norm (16% according to the AASP manual) almost 2–3 times 
more frequently among individuals with unipolar and anxiety 
disorders (25.8%, 44.8%, respectively). 
Seeking was found under norm mostly among individuals 
with unipolar disorders (74.2%) although the percentage of 
individuals with bipolar and anxiety disorders in this interval 
was also relatively 3–4 higher than in the general population.
Greater sensitivity was found among individuals with bi-
polar disorders (35%), however the percentage of individuals 
with unipolar and anxiety disorders above the norms, was 
also relatively high (28.1%, 24.1% respectively). A similar trend 
(bipolar: 25.8%, unipolar: 31.7%, anxiety: 17.2%) was found 
in regard to sensation avoiding. 
Correlations between SPD, duration of untreated 
illness, and duration of current episode 
As presented in Table 3, among unipolar participants, lon-
ger duration of current episode (days) significantly correlated 
with greater registration of sensory input (r=-0.25; p=0.02) 
and lower avoidance from sensory input. Among bipolar par-
ticipants, an opposite direction was found: longer duration of 
current episode (days) significantly correlated with lower reg-
istration of sensory input (r=0.28; p=0.04), greater tendency 
for sensory sensitivity (r=0.28; p=0.04) and sensation avoid-
ance (r=0.28; p=0.03). Among participants with anxiety dis-
orders, longer duration of current episode (days) significantly 
correlated with lower sensory sensitivity/avoidance (r=-0.49; 
p=0.01; r=-0.42; p=0.01, respectively). 
Correlation between SPD and severity of 
medication side effects 
Among bipolar participants, mean UKU score correlated 
with lower sensory sensitivity (r=-0.31, *p≤0.05) indicating 
that among these patients higher is UKU, the lower is the 
sensory sensitivity. 
DISCUSSION
This is the first study aimed to investigate the association 
between SPD, duration of untreated illness and current illness 
episode, as well as severity of medications side effects in a 
sample of psychiatric outpatients. The prevalence of SPD 
among patients with major affective and anxiety disorders 
was mainly expressed in elevated sensory sensitivity/avoid-
ance, low registration, and lower tendency for sensation 
seeking. While an extremely higher percentage of individuals 
was reported in all three groups in regard to lower tendency 
for sensation seeking, these trends were much more preva-
lent (69%, 44.8%, respectively) among subjects with anxiety. 
This may be related to the greater sensitivity and avoidance 
of these patients. Similar results were found in the study of 
Engel-Yeger and Dunn23 on healthy adults in which sensory 
sensitivity/avoidance profiles but also lower registering were 
related to enhanced anxiety trait. The authors suggested that 
lower registrators tend to miss sensory stimuli but once they 
do notice, they are overwhelmed.
Unipolar patients showed similar SPD trends as patients 
with anxiety disorders. Bipolar patients showed the highest 
Table 2. Frequency (in percentage) of participants in each sen-
sory processing pattern for every group
Unipolar 
(N=89)
Bipolar
(N=60)
Anxiety
(N=29)
Low registration
Under norm 25.8 18.3 44.8
Norm 47.2 41.7 44.8
Above norm
Missing
23.6
3.4
30
10
10.4
Seeking
Under norm 74.1 51.6 69
Norm 19.1 31.7 27.6
Above norm
Missing
3.4
3.4
1.7
15
0
3.4
Sensory sensitivity
Under norm 19.1 8.3 17.2
Norm 49.4 43.3 55.2
Above norm
Missing
28.1
3.4
35
13.3
24.1
3.4
Sensory avoidance
Under norm 16.9 15 20.7
Norm 52.8 41.7 58.6
Above norm 25.8 31.7 17.2
Missing 4.5 11.6 3.4
More than most people: one standard deviation above AASP normal 
range, Similar to most people: similar to AASP normal range, less 
than most people: one standard deviation below AASP normal range. 
AASP: Adolescent/Adult Sensory Profile
G Serafini et al. 
   www.psychiatryinvestigation.org  55
prevalence of subjects with sensation avoidance and sensitiv-
ity. Overall, this supports previous reports about the elevated 
vulnerability of patients with major affective and anxiety dis-
orders to impaired modulation of sensory input34 but also 
suggests that the expression of SPD in specific affective con-
ditions may be slightly different. 
Hence, clinicians may use sensory profiles in order to better 
understand mechanisms involved throughout the course of 
psychiatric disease. For example, it is known that sensory hy-
persensitivity might be an unrecognized contributing factor 
for anxiety and may exaggerate emotional related outcomes 
such as negative emotionality35 and depression.36 This trend 
may be more problematic when combined with lower seek-
ing and registration of sensory input. Indeed, these individu-
als may not actively seek for sensations in order to avoid them, 
as a coping mechanism. Reduced seeking and registration 
have been also related to depression, social isolation, impaired 
physical, cognitive and emotional status,37 impaired general 
health,38 and reduced participation in daily life activities.39 A 
better understanding of this fundamental topic could pro-
vide insights into whether the reported patient difficulties may 
reflect a specific emotional deficit or rather a generalized sen-
sory processing problem.40 
The above findings stress the need to refer to the SPD and 
their possible negative impacts on the individuals’ daily life but 
also refer to the possible interaction between SPD and clini-
cal characteristics. The importance to identify the main pre-
dictors associated with a poor outcome in patients with anxi-
ety and affective disorders is well known. In this regard, one 
of the most interesting variable which has been repeatedly 
investigated was duration of current illness episode. We found 
that among bipolar patients, longer duration of episode cor-
related with lower registration and greater sensitivity/avoid-
ance whereas we did not find any significant correlation be-
tween longer duration of untreated illness and SPD. An opposite 
trend was found among unipolar patients (where longer du-
ration of episode correlated with greater registration and great-
er avoidance) and patients with anxiety with regard to greater 
sensitivity/avoidance. 
Individuals with lower registration fail to detect sensation 
and do not actively seek for sensory input whereas individu-
als who actively limit exposure to sensations use strategies to 
avoid the unpleasant sensory experience and negative out-
comes.9 SPD may predispose bipolar subjects to develop a 
variety of occasionally maladaptive coping strategies in order 
to balance the disequilibrium resulting from the inability to 
integrate information.41 Bipolar patients may be defined in 
our study as a more vulnerable subgroup of subjects who are 
more likely to exhibit maladaptive coping strategies and a 
poorer psychosocial adjustment/participation in daily life ac-
tivities based on their SPD when compared with other groups.
Another interesting finding was that the severity of medi-
cation side effects (measured by mean UKU score) correlated 
with lower sensory sensitivity only among bipolar participants; 
therefore the higher is the UKU mean total score, the lower 
is the sensory sensitivity.
To our knowledge, there are no previous studies in the liter-
ature about the predictive potential of sensory patterns to 
distinguish between individuals with higher or lower perceived 
severity of side effects related to psychoactive treatments. Ac-
cording to our findings, patients with lower sensory sensitiv-
ity (bipolar subjects in this study) may be more likely to ex-
perience higher severity of side effects related to medications 
but it’s important to note that these individuals may also pres-
ent an increased likelihood of perceiving these side effects. 
Bipolar subjects also showed a higher prevalence of hyper-
sensitivity (above 30% for sensitivity and avoidance). Hyper-
sensitivity is known to be related to greater somatization, great-
er intensification of pain,22 hypervigilance, increased level of 
attention and arousal,42 all of which may significantly impact 
on the perceived severity of medications side effects. Side ef-
fects that significantly enhance functional limitations should 
be early recognized by clinicians in order to avoid significant 
distress. Also, the optimized selection of psychoactive medi-
Table 3. Correlations between SPD, duration of untreated illness and of current episode, and medication side effects in each group
Sensory profiles Low registration Sensation seeking Sensory sensitivity Sensation avoiding
Duration of current episode (days) -0.25*
0.28*
NS
NS
NS
NS
NS
0.28*
-0.49**
-0.27*
0.28*
-0.42*
Duration of untreated illness (years) NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
Mean UKU NS
NS
NS
NS
NS
NS
NS
-0.31*
NS
NS
NS
NS
Unipolar (N=83), bipolar (N=54), anxiety (N=26). *p≤0.05, **p≤0.01. NS: not significant, SPD: sensory processing disorders, UKU: Udvalg 
for Kliniske Undersøgelser
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cations which takes adequately into account the perceived 
subjective severity of medications side effects may directly 
impact on treatment adherence.43,44 However, this is a com-
plex issue that should be further investigated by prospective 
studies recruiting larger samples.
In summary, the results of the present study suggest that 
subjects with major affective and anxiety disorders commonly 
suffer from SPD that may be associated with specific clinical 
characteristics which are able to influence the perceived dis-
ability and long-term course of the illness. A better understand-
ing of the impact of SPD on daily life of patients with major 
affective and anxiety disorder may contribute to research and 
practice related to these patients improving possible inter-
vention benefits as well as quality of life. 
Our results should be interpreted in the light of the follow-
ing limitations. First, the number of participants was relatively 
low and the study may be underpowered. Thus, the results 
should be replicated in further larger samples. The cross-sec-
tional study design with the observed associations do not rep-
resent causal relationships between the investigated parame-
ters as well. Second, all patients have been selected as outpatients. 
In addition, given the great variability among participants, it 
would have been helpful to control for possible confounding 
socio-demographic variables. Unfortunately, we were not able 
to control for possible confounders such as age, socio-eco-
nomic status, age of illness onset, and illness duration. Finally, 
the possible confounding effect of psychoactive medications 
(e.g., antidepressants, mood-stabilizers, antipsychotics, and 
benzodiazepines) was not analyzed. In this regard, it’s also 
important to note that medications side effects should be con-
sidered as not specific, since all patients were taking multiple 
psychoactive medications. However, patients were all con-
secutive outpatients who had visited our hospital for at least 
6 months and whose medication regimens had been stable 
for at least 6 months prior to recruitment. Moreover, psycho-
active medications seem to not significantly affect sensory 
processing patterns who are supposed to be not state-related 
but rather stable patterns over the lifespan.45 
In conclusion, this is, to our knowledge, the first prelimi-
nary study examining the association of SPD with clinical 
variables of patients with major affective and anxiety disor-
ders and its impact on the long term course. Importantly, in 
addition to the frequent reports of hypersensitivity, we 
stressed the negative impact of hyposensitivity in subjects 
with major affective and anxiety disorders, in particular 
when related to lower registration, or alternatively the resil-
ient role of SPD when referring to sensory seeking. Accord-
ing to our recent published studies,46,47 the inclusion of mea-
sures of sensory processing patterns may provide relevant 
insights into the multiple determinants involved in the emer-
gence/maintenance of major affective disorders.
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